The Hain Celestial Group (HAIN)
(Delayed Data from NSDQ)
$7.53 USD
+0.40 (5.61%)
Updated Jul 16, 2024 04:00 PM ET
After-Market: $7.54 +0.01 (0.13%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$7.53 USD
+0.40 (5.61%)
Updated Jul 16, 2024 04:00 PM ET
After-Market: $7.54 +0.01 (0.13%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth B Momentum A VGM
Zacks News
Hain Celestial (HAIN) Issues Soft Preliminary Results for Q4
by Zacks Equity Research
Hain Celestial (HAIN) announces weak preliminary results for fourth-quarter fiscal 2022. Volatile backdrop in Europe and unfavorable currency movements hurt the results.
Hain Celestial's (HAIN) Q3 Earnings Miss Mark, Sales Rise Y/Y
by Zacks Equity Research
Hain Celestial (HAIN) reports weak performance in third-quarter fiscal 2022 on high inflations, supply-chain disruptions, ingredient and package shortages.
Hain Celestial (HAIN) Misses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Hain Celestial (HAIN) delivered earnings and revenue surprises of -28.26% and 4.69%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Freshpet (FRPT) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Freshpet (FRPT) delivered earnings and revenue surprises of -11.11% and 4.68%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Factors Influencing Constellation Brands' (STZ) Q4 Earnings
by Zacks Equity Research
Constellation Brands' (STZ) Q4 earnings are expected to have been hurt by soft wine & spirits, and higher costs. Strength in the beer business and premiumization efforts are likely to have aided.
Hain Celestial's (HAIN) Q2 Earnings Beat Estimates, Sales Soft
by Zacks Equity Research
Hain Celestial (HAIN) posts mixed results for second-quarter fiscal 2022. HAIN witnesses inflation, and industry-wide distribution and warehousing costs in the quarter.
Hain Celestial (HAIN) Surpasses Q2 Earnings Estimates
by Zacks Equity Research
Hain Celestial (HAIN) delivered earnings and revenue surprises of 9.09% and 0.67%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Food Stocks' Earnings Lineup on Feb 3: HSY, HAIN & POST
by Zacks Equity Research
Food stocks have been gaining on efforts to boost portfolio and favorable demand while high costs are a concern. Hershey (HSY), Hain Celestial (HAIN), and Post Holdings (POST) are due to report earnings.
Things to Know Before Hain Celestial's (HAIN) Q2 Earnings
by Zacks Equity Research
Hain Celestial's (HAIN) second-quarter fiscal 2022 results might have been hurt by high inflation, labor shortages, increased freight cost and major overlaps related to COVID-19.
Earnings Preview: Hain Celestial (HAIN) Q2 Earnings Expected to Decline
by Zacks Equity Research
Hain Celestial (HAIN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Altria (MO) Benefits From Robust Pricing & RRP Expansion
by Zacks Equity Research
Altria (MO) is gaining on its strong pricing power and efforts to expand in the reduced risk products space amid weak cigarette volumes.
Mondelez (MDLZ) Gains on Buyouts, Pricing Amid High Costs
by Zacks Equity Research
Mondelez International (MDLZ) is focused on solidifying its portfolio through buyouts. Also, strength in emerging markets and pricing have been aiding it amid inflated costs.
Helen of Troy (HELE) Adds Osprey, Strengthens Leadership Brands
by Zacks Equity Research
Helen of Troy (HELE) closes the buyout of Osprey Packs. It is likely to be an addition to the company's Leadership Brands' portfolio and is expected to augment the top and bottom lines.
Nu Skin's (NUS) Transformational Strategies Keep It Well-Placed
by Zacks Equity Research
Nu Skin (NUS) gains on its solid customer base and network of sales leaders. The company's three transformational strategies also bode well amid pandemic-led disruptions.
Sysco (SYY) Looks Well-Placed for 2022 on Recipe for Growth
by Zacks Equity Research
Sysco (SYY) benefits from its Recipe for Growth program and away-from-home food demand amid escalated costs.
Forget Conagra Brands (CAG), Focus on These 3 Food Stocks for 2022
by Vrishali Bagree
Conagra Brands (CAG) looks troubled due to cost inflation. Food companies like Hain Celestial (HAIN), United Natural (UNFI) and Kellogg (K) look well placed for 2022 on the back of their strategic growth efforts.
Medifast (MED) Gains on OPTAVIA Strength, SG&A Costs Rise
by Zacks Equity Research
Medifast (MED) has been gaining on strength of its OPTAVIA lifestyle solution and coaching support system, which was a major driver in the third quarter.
Archer Daniels (ADM) Boosts Flavor Business Via Latest Buyout
by Zacks Equity Research
Archer Daniels' (ADM) recent acquisition of Flavor Infusion is set to help it expand the customer base across Latin America & the Caribbean along with drive growth in the highly-valued flavor space.
Kimberly-Clark (KMB) Looks Troubled on Escalated Input Costs
by Zacks Equity Research
Kimberly-Clark (KMB) has been encountering escalated input costs. Key input costs are estimated to escalate in the range of $1,400-$1,500 million in 2021.
Lamb Weston's (LW) Stock Falls 22% in 6 Months on Input Costs
by Zacks Equity Research
Lamb Weston (LW) has been encountering escalated input costs and high SG&A costs. For fiscal 2022, management expects net income and adjusted EBITDA to be under pressure.
Conagra (CAG) Appears to be in Trouble on Cost Inflation
by Zacks Equity Research
Conagra (CAG) has been encountering cost of goods sold, inflation and high SG&A costs. Management expects cost inflation of nearly 11% in fiscal 2022.
TreeHouse Foods (THS) Looks Troubled: High Costs a Key Concern
by Zacks Equity Research
TreeHouse Foods (THS) has been battling escalated cost inflation. Management lowered its earnings guidance for 2021 on its last earnings call.
Lamb Weston (LW) Hikes Dividend, Unveils Share Buyback Plan
by Zacks Equity Research
Lamb Weston (LW) rewards shareholders by raising dividend and approving additional share buybacks.
Mesa Laboratories and Disney have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Mesa Laboratories and Disney have been highlighted as Zacks Bull and Bear of the Day
The J.M. Smucker (SJM) to Sell Few Businesses to Optimize Portfolio
by Zacks Equity Research
The J.M. Smucker (SJM) will offload its natural and organic beverage as well as grains businesses to Nexus Capital Management LP by third-quarter fiscal 2022.